InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: None

Monday, 08/02/2021 8:00:11 AM

Monday, August 02, 2021 8:00:11 AM

Post# of 44690
About APPLIED PHARMA RESEARCH a Relief Therapeutics Holding AG company ——— Despite the success of laser refractive surgery to correct low order aberrations,
the incidence of postoperative symptoms remains to be relatively high.
EYE LASER SURGERY
In particular, estimates indicate that 53% of patients experienced at least one side effect within the first four weeks after surgery, as well as 22% experienced them six months after surgery, especially related to the inflammation and corneal healing.
These visual outcomes can reduce the quality of life of patients and are a key factor impacting the poor level of satisfaction of surgery.
Current treatments are antibiotic and corticosteroids, which however can have side effects, the former causing resistance while the latter causing delay in healing and worsening infections.

https://www.apr.ch/apr-pharma-products/therapeutic-pharma/eye-laser-surgery/

The regulatory role of vasoactive intestinal peptide in lacrimal gland ductal fluid secretion: A new piece of the puzzle in tear production ——— Vasoactive intestinal peptide (VIP) is an important regulator of lacrimal gland (LG) function although the effect of VIP on ductal fluid secretion is unknown. Therefore, the aim of the present study was to investigate the role of VIP in the regulation of fluid secretion of isolated LG ducts and to analyze the underlying intracellular mechanisms.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722779/

THE AMAZING NEUROPEPTIDE ——— VIP plays an important role in visual development. Nasal administration of VIP can improve the function of neurons in the LGBd of kittens and has a certain therapeutic effect on amblyopia.

https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-019-1203-1

Global Amblyopia Market was valued at USD 4327.0 Million in 2016, and is forecasted to grow at CAGR of 3.28% over the forecast period 2020-2026. The key factors driving the market growth include growing prevalence of ophthalmological disorders, increasing technological advancement and high healthcare expenditure.

https://dataintelo.com/report/amblyopia-market-report/